Snap-8 10 mg
Also known as · Acetyl Octapeptide-3
Snap-8 is an extended argireline-family peptide widely used in topical cosmetic-formulation research.
Chemistry quick-facts
- CAS
- 868844-74-0
- Formula
- C37H66N12O10
- MW
- 894.01 Da
- Length
- 8 aa
- Status
- Cosmetic ingredient. No therapeutic approval.
- Purity (HPLC)
- ≥ 99.0%
Mechanism of action
Proposed: SNAP-25-domain competitive inhibition of SNARE-complex assembly in topical formulation research.
Research context
Snap-8 is a synthetic octapeptide developed as an elongation of the SNAP-25 protein fragment on which argireline (Acetyl Hexapeptide-3) is based. It is widely used as a cosmetic-formulation ingredient in expression-line research.
Reconstitution
- Solvent
- Bacteriostatic water for injection (0.9% benzyl alcohol) — included with kit
- Typical volume
- 1 – 2 mL
- · Inject diluent slowly down the side of the vial onto the cake.
- · Swirl gently — do not shake.
- · Solution should be clear and colourless. Discard if not.
Storage
- Lyophilised
- −20 °C, desiccated, protected from light. Stable at 15–25 °C for up to 30 days in transit.
- Reconstituted
- 2–8 °C, original vial, consumed within 4 weeks.
- Shelf life — sealed
- 24 months from date of manufacture when stored lyophilised at −20 °C.
This page summarises the research literature on Snap-8 10 mg for in vitro laboratory investigation only. It is not medical advice, not a treatment recommendation, and not a substitute for a qualified physician. Material is sold for analytical chemistry and cell-culture research, not for human or veterinary administration.
- ResearchGHK-Cu 100 mg
Copper-bound tripeptide. Deep-blue lyophilised cake — the visual signature of intact Cu²⁺ coordination.
- ResearchGlow Blend 70 mg
ChemAesthetic's multi-peptide dermal blend. Combines GHK-Cu with complementary signalling peptides commonly co-studied in dermal-regeneration research
- ResearchGHK-Cu 150 mg pen
High-dose GHK-Cu pen from Astranordic. 1.5× the dose of the standard 100 mg vial, in a pre-filled research pen.
- Biomarkerhs-CRP 2.5 mg/L
High-sensitivity C-reactive protein at 2.5 mg/L sits in the 'intermediate cardiovascular risk' category most cardiology research uses. What it measures, what drives it, and how to interpret your number.
- ComparisonGHK-Cu vs generic "copper peptides" — what's actually in the bottle
Most products marketed as "copper peptides" contain GHK-Cu specifically — but not all. The research literature on GHK-Cu is far ahead of any other copper-peptide complex.
- ComparisonGHK-Cu injectable vs topical — what the research literature shows
GHK-Cu research splits between injectable (subcutaneous) and topical (cosmetic / wound-healing) routes. Different penetration, different research applications.